Search

everythinglearnresearchcommunity

for

Search:↓

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

M2 macrophages, a type of immune cell, help in new hair growth on scars by producing growth factors.

lncRNAs are important for understanding and treating skin diseases.

NLRP3 helps control inflammation and repair in wound healing, making it a potential target for treatment.

Certain RNAs may help diagnose alopecia areata by affecting keratin genes.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

The nodule was a benign cutaneous lymphadenoma, not cancer, and was successfully removed.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

Mitf plays a key role in melanoma progression and is linked to disease stage.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Integrin β1 is crucial for liver structure and function, preventing fibrosis.

Folliculotropic mycosis fungoides can affect the central nervous system in advanced stages.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Alopecia Areata can develop without perforin-mediated cytolysis.

Blocking certain proteins can significantly regrow hair in severe alopecia areata.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

A rare skin infection in a 10-year-old kidney transplant patient was successfully managed by adjusting medication.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

NSC167409 can effectively inhibit the virus causing hand, foot, and mouth disease.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

A pathway helps maintain long telomeres in both stem and cancer cells.